Fabry's disease: Difference between revisions
No edit summary |
Ghsanadgol (talk | contribs) No edit summary |
||
(54 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Name = Fabry disease| | Name = Fabry disease| | ||
Line 14: | Line 15: | ||
MeshID = D000795 | | MeshID = D000795 | | ||
}} | }} | ||
{{ | {{Fabry's disease}} | ||
{{CMG}}; {{AE}} | |||
== | ==[[Fabry's disease overview|Overview]] == | ||
* | |||
* | |||
== | ==[[Fabry's disease historical perspective|Historical Perspective]]== | ||
== | ==[[Fabry's disease classification|Classification]]== | ||
== | ==[[Fabry's disease pathophysiology|Pathophysiology]]== | ||
== | ==[[Fabry's disease causes|Causes]]== | ||
== | |||
==[[Fabry's disease differential diagnosis|Differentiating Fabry's disease from other Diseases]]== | |||
==[[Fabry's disease epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Fabry's disease risk factors|Risk Factors]]== | |||
== | ==[[Fabry's disease screening|Screening]]== | ||
==[[Fabry's disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
==Treatment== | ==Treatment== | ||
== | [[Fabry's disease medical therapy|Medical Therapy]] | [[Fabry's disease surgery|Surgery]] | [[Fabry's disease primary prevention|Primary Prevention]] | [[Fabry's disease secondary prevention|Secondary Prevention]] | [[Fabry's disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fabry's disease future or investigational therapies|Future or Investigation Therapies]] | ||
==Case Studies== | |||
[[Fabry's disease case study one|Case #1]] | |||
==External links== | ==External links== | ||
* [http://www.fabry.org/FSIG.nsf/Pages2/HomePage Fabry Support & Information Group] | * [http://www.fabry.org/FSIG.nsf/Pages2/HomePage Fabry Support & Information Group] | ||
* {{NINDS|fabrys}} | * {{NINDS|fabrys}} | ||
* {{NLM|fabrydisease}} | * {{NLM|fabrydisease}} | ||
* [http://www.apmf-fabry.org/ Fabry's Disease Association] | * [http://www.apmf-fabry.org/ Fabry's Disease Association] | ||
== References == | |||
[1] Caterina Bartolotta, Marcello Filogamo, Paolo Colomba, Carmela Zizzo, Giuseppe Albeggiani, Simone Scalia, Daniele Francofonte, Giuseppe Cammarata, Vincenzo Savica, Giovanni Duro, FP907 | |||
HISTORY OF ANDERSON - FABRY DISEASE, ''Nephrology Dialysis Transplantation'', Volume 30, Issue suppl_3, 1 May 2015, Page iii379, <nowiki>https://doi.org/10.1093/ndt/gfv186.08</nowiki> | |||
{{WikiDoc Help Menu}} | |||
[[ | [2] Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. ''Genet Med'' 2006;8: 539–548. | ||
[3] Elleder M, Poupĕtová H, Kozich V . Fetal pathology in Fabry’s disease and mucopolysaccharidosis type I. ''Cesk Patol'' 1998;34:7–12. | |||
[4] Thurberg BL, Politei JM . Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. ''Hum Pathol'' 2012;43:610–614. | |||
[[fr:Maladie de Fabry]] | [[fr:Maladie de Fabry]] | ||
[ | [5] Deegan PB, Baehner AF, Barba Romero MA, Hughes DA, Kampmann C, Beck M; European FOS Investigators. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet. 2006 Apr;43(4):347-52. Epub 2005 Oct 14. Citation on PubMed or Free article on PubMed Central | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] |
Latest revision as of 20:07, 23 May 2022
Template:DiseaseDisorder infobox
Fabry's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fabry's disease On the Web |
American Roentgen Ray Society Images of Fabry's disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fabry's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigation Therapies
Case Studies
External links
- Fabry Support & Information Group
- Template:NINDS
- Fabry's disease at NLM Genetics Home Reference
- Fabry's Disease Association
References
[1] Caterina Bartolotta, Marcello Filogamo, Paolo Colomba, Carmela Zizzo, Giuseppe Albeggiani, Simone Scalia, Daniele Francofonte, Giuseppe Cammarata, Vincenzo Savica, Giovanni Duro, FP907 HISTORY OF ANDERSON - FABRY DISEASE, Nephrology Dialysis Transplantation, Volume 30, Issue suppl_3, 1 May 2015, Page iii379, https://doi.org/10.1093/ndt/gfv186.08
[2] Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med 2006;8: 539–548.
[3] Elleder M, Poupĕtová H, Kozich V . Fetal pathology in Fabry’s disease and mucopolysaccharidosis type I. Cesk Patol 1998;34:7–12.
[4] Thurberg BL, Politei JM . Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. Hum Pathol 2012;43:610–614. [5] Deegan PB, Baehner AF, Barba Romero MA, Hughes DA, Kampmann C, Beck M; European FOS Investigators. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet. 2006 Apr;43(4):347-52. Epub 2005 Oct 14. Citation on PubMed or Free article on PubMed Central